{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:01:09Z","timestamp":1787169669032,"version":"build-2736575974"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Mucormycosis is a rare but life-threatening opportunistic fungal infection caused by a group of molds that belong to Zygomycetes of the order Mucorales. These fungi are found in the environment such as soil, decaying vegetation, and organic matters. Sporangiospores present in the environment enter the human body through inhalation or direct skin inoculation by trauma or ingestion and result in pulmonary, cutaneous, and gastrointestinal mucormycosis, respectively, in immunocompromised hosts. Patients with uncontrolled diabetes, hematological malignancies, high-dose glucocorticoid therapy, iron overload, and organ transplantation are at high risk of acquiring mucormycosis. The second wave of severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] affected India severely with the highest number of cases and deaths compared to all other countries. Additionally, the country was affected by emergence of rare but life-threatening mucormycosis. Currently, many coronavirus disease 2019 patients with underlying risk factors such as uncontrolled diabetes, high-dose steroid therapy, and exposure to mechanical ventilation have developed mucormycosis. Inhalation is the most common mode of transmission that results in colonization of sporangiospores in the nose. In immunocompromised host, sporangiospores germinate, and subsequently form hyphae. These hyphae invade into tissues, and produce tissue infarction, necrosis, and thrombosis. Angioinvasion causes hematogenous dissemination to many organs, predominantly to brain, that result in rhino-orbital-cerebral mucormycosis. Clinical characteristics, radio imaging, fungal culture, histopathology, and molecular techniques are the key diagnostic methods. Surgical intervention and aggressive antifungal therapy are the main management strategies. Amphotericin B is the drug of choice for treatment of mucormycosis, whereas posaconazole or isavuconazole is used for step-down therapy and salvage therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijciis.ijciis_48_21","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T07:35:02Z","timestamp":1648020902000},"page":"38-46","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Storm of a rare opportunistic life threatening mucormycosis among post COVID-19 patients"],"prefix":"10.4103","volume":"12","author":[{"given":"Mohan Bilikallahalli","family":"Sannathimmappa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Aravindakshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20240902","first-page":"1","article-title":"Emerging and re-emerging viral infections in the 21 century: Microbiological and public health perspectives","volume":"10","author":"Sannathimmappa","year":"2021","journal-title":"J Krishna Inst Med Sci Univ"},{"key":"R2-8-20240902","doi-asserted-by":"crossref","first-page":"146","DOI":"10.23937\/2474-3658\/1510146","article-title":"COVID-19: An Insight into SARS-CoV-2 Pandemic Originated at Wuhan City in Hubei Province of China","volume":"6","author":"Mohan","year":"2020","journal-title":"J Infect Dis Epidemiol"},{"key":"R3-8-20240902","doi-asserted-by":"crossref","first-page":"ofab201","DOI":"10.1093\/ofid\/ofab201","article-title":"Characterization of bacterial and fungal infections in hospitalized patients with COVID-19 and factors associated with healthcare-associated infections","volume":"8","author":"Kubin","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"R4-8-20240902","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R5-8-20240902","first-page":"e10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"R6-8-20240902","doi-asserted-by":"crossref","first-page":"100900","DOI":"10.1016\/j.cegh.2021.100900","article-title":"Mucormycosis: A deadly black fungus infection among COVID-19 patients in India","volume":"12","author":"Choudhary","year":"2021","journal-title":"Clin Epidemiol Glob Health"},{"key":"R7-8-20240902","first-page":"100057","article-title":"Mucormycosis in COVID-19 pandemic: Risk factors and linkages","volume":"2","author":"Kumar","year":"2021","journal-title":"Curr Res Microb Sci"},{"key":"R8-8-20240902","doi-asserted-by":"crossref","first-page":"E265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: An update","volume":"6","author":"Skiada","year":"2020","journal-title":"J Fungi (Basel"},{"key":"R9-8-20240902","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.3390\/jof5040106","article-title":"Updates on the taxonomy of mucorales with an emphasis on clinically important taxa","volume":"5","author":"Walther","year":"2019","journal-title":"J Fungi (Basel"},{"key":"R10-8-20240902","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: Pathophysiology, presentation, and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R11-8-20240902","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.sjbs.2012.06.002","article-title":"Fungal pollution of indoor environments and its management","volume":"19","author":"Haleem Khan","year":"2012","journal-title":"Saudi J Biol Sci"},{"key":"R12-8-20240902","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"R13-8-20240902","doi-asserted-by":"crossref","first-page":"E431","DOI":"10.1503\/cmaj.191364","article-title":"Mucormycosis in a 40-year-old woman with diabetic ketoacidosis","volume":"192","author":"Thomas","year":"2020","journal-title":"CMAJ"},{"key":"R14-8-20240902","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/abd1806-4841.20176614","article-title":"Cutaneous mucormycosis","volume":"92","author":"CastrejBn-Pyrez","year":"2017","journal-title":"An Bras Dermatol"},{"key":"R15-8-20240902","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1186\/s12879-020-05548-9","article-title":"Gastrointestinal mucormycosis due to Rhizopus microsporus following Streptococcus pyogenes toxic shock syndrome in an HIV patient: A case report","volume":"20","author":"Yinadsawaphan","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R16-8-20240902","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R17-8-20240902","doi-asserted-by":"crossref","first-page":"e241663","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID-19 triggering mucormycosis in a susceptible patient: A new phenomenon in the developing world?","volume":"14","author":"Revannavar","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R18-8-20240902","doi-asserted-by":"crossref","first-page":"101161","DOI":"10.1016\/j.mycmed.2021.101161","article-title":"Mucormycosis: A killer in the shadow of COVID-19","volume":"31","author":"Suvvari","year":"2021","journal-title":"J Mycol Med"},{"key":"R19-8-20240902","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/myc.13335","article-title":"ECMM and ISHAM. ECMM\/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in lowand middle-income countries","volume":"64","author":"Rudramurthy","year":"2021","journal-title":"Mycoses"},{"key":"R20-8-20240902","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4081\/cp.2020.1271","article-title":"COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review","volume":"10","author":"Cavezzi","year":"2020","journal-title":"Clin Pract"},{"key":"R21-8-20240902","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mmcr.2020.05.008","article-title":"A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well-controlled diabetic patient","volume":"29","author":"Hoang","year":"2020","journal-title":"Med Mycol Case Rep"},{"key":"R22-8-20240902","doi-asserted-by":"crossref","first-page":"69","DOI":"10.15406\/jbmoa.2021.09.00298","article-title":"A contemporary intimidation for COVID-19 patients coinfected with mucormycosis in India","volume":"9","author":"Bhat","year":"2021","journal-title":"J Bacteriol Mycol Open Access"},{"key":"R23-8-20240902","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10096-014-2076-0","article-title":"Biology, systematics, and clinical manifestations of Zygomycota infections","volume":"33","author":"Muszewska","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R24-8-20240902","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12281-019-0337-1","article-title":"Mucormycosis: Pathogenesis and pathology","volume":"13","author":"Challa","year":"2019","journal-title":"Curr Fungal Infect Rep"},{"key":"R25-8-20240902","doi-asserted-by":"crossref","first-page":"e00172","DOI":"10.1128\/AAC.00172-18","article-title":"In Situ Validation of the endothelial cell receptor GRP78 in a case of rhinocerebral mucormycosis","volume":"62","author":"Shumilov","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R26-8-20240902","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/jpids\/pix053","article-title":"Recognition and clinical presentation of invasive fungal disease in neonates and children","volume":"6","author":"King","year":"2017","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R27-8-20240902","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.3390\/jof3030048","article-title":"Innate and adaptive immunity to mucorales","volume":"3","author":"Ghuman","year":"2017","journal-title":"J Fungi (Basel"},{"key":"R28-8-20240902","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/AAC.01136-07","article-title":"Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage","volume":"52","author":"Chamilos","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-8-20240902","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1590\/S0100-879X2006005000143","article-title":"Neutrophil function and metabolism in individuals with diabetes mellitus","volume":"40","author":"Alba-Loureiro","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"R30-8-20240902","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.3390\/jof5030059","article-title":"Mucormycosis of the central nervous system","volume":"5","author":"Chikley","year":"2019","journal-title":"J Fungi (Basel"},{"key":"R31-8-20240902","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.3390\/jof6020094","article-title":"Mucorales species and macrophages","volume":"6","author":"Nicolzs","year":"2020","journal-title":"J Fungi (Basel"},{"key":"R32-8-20240902","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.3390\/jof5020027","article-title":"Animal models to study mucormycosis","volume":"5","author":"Jacobsen","year":"2019","journal-title":"J Fungi (Basel"},{"key":"R34-8-20240902","doi-asserted-by":"crossref","first-page":"E1296","DOI":"10.3390\/genes11111296","article-title":"Iron assimilation during emerging infections caused by opportunistic fungi with emphasis on mucorales and the development of antifungal resistance","volume":"11","author":"Stanford","year":"2020","journal-title":"Genes (Basel"},{"key":"R35-8-20240902","doi-asserted-by":"crossref","first-page":"100864","DOI":"10.1016\/j.mam.2020.100864","article-title":"Iron in infection and immunity","volume":"75","author":"Nairz","year":"2020","journal-title":"Mol Aspects Med"},{"key":"R36-8-20240902","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/QCO.0b013e3283165fd1","article-title":"Iron acquisition: A novel prospective on mucormycosis pathogenesis and treatment","volume":"21","author":"Ibrahim","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"R37-8-20240902","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11046-013-9693-5","article-title":"Siderophore production by pathogenic mucorales and uptake of deferoxamine B","volume":"176","author":"Larcher","year":"2013","journal-title":"Mycopathologia"},{"key":"R38-8-20240902","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash","year":"2019","journal-title":"J Fungi (Basel"},{"key":"R39-8-20240902","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1086\/597615","article-title":"Increased virulence of zygomycetes organisms following exposure to voriconazole: A study involving fly and murine models of zygomycosis","volume":"199","author":"Lamaris","year":"2009","journal-title":"J Infect Dis"},{"key":"R40-8-20240902","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/jac\/dks189","article-title":"Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: Real-life data from a single-centre institutional retrospective observational study","volume":"67","author":"Auberger","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"R41-8-20240902","first-page":"1621","article-title":"Breakthrough invasive mold infections in the hematology patient: Current concepts and future directions","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R42-8-20240902","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: The RetroZygo study (2005\u22122007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R43-8-20240902","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3201\/eid1609.100276","article-title":"Increasing incidence of mucormycosis in University Hospital, Belgium","volume":"16","author":"Saegeman","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"R44-8-20240902","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: The perfect storm for mucormycosis","volume":"7","author":"John","year":"2021","journal-title":"J Fungi (Basel"},{"key":"R45-8-20240902","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S2213-2600(21)00265-4","article-title":"Rising incidence of mucormycosis in patients with COVID-19: Another challenge for India amidst the second wave?","volume":"9","author":"Raut","year":"2021","journal-title":"Lancet Respir Med"},{"key":"R47-8-20240902","doi-asserted-by":"crossref","first-page":"E319","DOI":"10.3390\/medicina55070319","article-title":"Invasive and non-invasive fungal rhinosinusitis \u2212 A review and update of the evidence","volume":"55","author":"Deutsch","year":"2019","journal-title":"Medicina (Kaunas"},{"key":"R48-8-20240902","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"Sarkar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R49-8-20240902","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/mmy\/myx017","article-title":"Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases","volume":"56","author":"Corzo-LeBn","year":"2018","journal-title":"Med Mycol"},{"key":"R50-8-20240902","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0970-2113.148452","article-title":"Pulmonary tuberculosis and mucormycosis co-infection in a diabetic patient","volume":"32","author":"Aggarwal","year":"2015","journal-title":"Lung India"},{"key":"R51-8-20240902","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/cit929","article-title":"The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?","volume":"58","author":"Legouge","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R52-8-20240902","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1097\/RLU.0b013e3182867d13","article-title":"Utility of 18F-FDG PET\/CT in diagnosis and management of mucormycosis","volume":"38","author":"Liu","year":"2013","journal-title":"Clin Nucl Med"},{"key":"R53-8-20240902","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s15010-017-1072-6","article-title":"Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: A 12-year experience","volume":"45","author":"Lass-FlErl","year":"2017","journal-title":"Infection"},{"key":"R54-8-20240902","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1469-0691.2009.02999.x","article-title":"Zygomycosis: Conventional laboratory diagnosis","volume":"15","author":"Lass-FlErl","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"R55-8-20240902","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","volume":"54","author":"Walsh","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R56-8-20240902","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3343\/alm.2016.36.1.60","article-title":"Identification of mucorales from clinical specimens: A 4-year experience in a single institution","volume":"36","author":"Yang","year":"2016","journal-title":"Ann Lab Med"},{"key":"R57-8-20240902","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3389\/fmicb.2019.02903","article-title":"A new age in molecular diagnostics for invasive fungal disease: Are we ready?","volume":"10","author":"Kidd","year":"2019","journal-title":"Front Microbiol"},{"key":"R58-8-20240902","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: Retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)","volume":"22","author":"Millon","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R59-8-20240902","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/ijo.IJO_3774_20","article-title":"Mucor in a viral land","volume":"69","author":"Mrittika","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R60-8-20240902","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"R61-8-20240902","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R62-8-20240902","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of Amphotericin B: An overview of the main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect Dis Ther"},{"key":"R63-8-20240902","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/DDDT.S145545","article-title":"Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: Design, development, and place in therapy","volume":"12","author":"Jenks","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"R64-8-20240902","first-page":"528","article-title":"Intravenous and oral posaconazole pharmacokinetics in a five-year-old with mucor: A case report and review of the literature","volume":"24","author":"Ruland","year":"2019","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R67-8-20240902","first-page":"89","article-title":"The endoscope and instruments for minimally invasive neurosurgery","volume":"4","author":"Shaikh","year":"2020","journal-title":"Mini Invasive Surg"},{"key":"R68-8-20240902","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.3892\/etm.2017.4986","article-title":"Diagnosis and treatment of pulmonary mucormycosis: A case report","volume":"14","author":"Luo","year":"2017","journal-title":"Exp Ther Med"},{"key":"R69-8-20240902","first-page":"101082","article-title":"Pulmonary mucormycosis with extensive bronchial necrosis and bronchomediastinal fistula: A case report and review","volume":"30","author":"Seifert","year":"2020","journal-title":"Respir Med Case Rep"},{"key":"R70-8-20240902","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R71-8-20240902","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R72-8-20240902","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1179\/joc.2009.21.3.322","article-title":"Zygomycosis in Italy: A survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)","volume":"21","author":"Pagano","year":"2009","journal-title":"J Chemother"},{"key":"R73-8-20240902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-2023-z","article-title":"Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: A retrospective study","volume":"16","author":"Kontoyiannis","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R74-8-20240902","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/myc.12958","article-title":"Mucormycosis in South America: A review of 143 reported cases","volume":"62","author":"Nucci","year":"2019","journal-title":"Mycoses"},{"key":"R75-8-20240902","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R76-8-20240902","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R77-8-20240902","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.mycmed.2018.02.014","article-title":"Mucormycosis in Iran: A six-year retrospective experience","volume":"28","author":"Dolatabadi","year":"2018","journal-title":"J Mycol Med"},{"key":"R78-8-20240902","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/myc.12474","article-title":"Mucormycosis in Iran: A systematic review","volume":"59","author":"Vaezi","year":"2016","journal-title":"Mycoses"},{"key":"R79-8-20240902","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s15010-018-1195-4","article-title":"Mucormycosis in hospitalized patients at a tertiary care center in Lebanon: A case series","volume":"46","author":"El-Zein","year":"2018","journal-title":"Infection"},{"key":"R80-8-20240902","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cmi.2016.01.005","article-title":"Mucormycosis in Australia: Contemporary epidemiology and outcomes","volume":"22","author":"Kennedy","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R81-8-20240902","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/myc.13123","article-title":"Mucormycosis in the middle east and North Africa: Analysis of the FungiScope\u00ae registry and cases from the literature","volume":"63","author":"Stemler","year":"2020","journal-title":"Mycoses"}],"container-title":["International Journal of Critical Illness and Injury Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijciis.ijciis_48_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:10:25Z","timestamp":1787166625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijciis.ijciis_48_21"}},"subtitle":["A tale of two pathogens"],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijciis.ijciis_48_21","relation":{},"ISSN":["2229-5151"],"issn-type":[{"value":"2229-5151","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}